Intrauterine Treatment of Nonimmune Fetal Dropsy with Type I Cystic Adenomatous Lung Malformation
https://doi.org/10.31550/1727-2378-2024-23-2-60-64
Abstract
Aim. To present the experience of using a thoracoamniotic bypass for the treatment of a fetus diagnosed with nonimmune fetal dropsy, against the background of cystic adenomatous lung malformation type I.
Key points. Congenital cystic adenomatous pulmonary malformation (CAPRL) is a benign lung lesion that appears before birth as a cyst or mass in the chest. The macrocystic form of this defect is associated with a significant risk of pulmonary hypoplasia, pleural effusion, and non-immune fetal hydrops. We present our own observation of a patient with type 1 CAPRL in the fetus and signs of non-immune hydrops.
Conclusion. The use of intrauterine thoraco-amniotic shunting can stop the manifestations of hydrops in type I CAPRL in the fetus.
About the Authors
N. V. Kosovtsova
Ural Research Institute of Maternal and Infant Care
Russian Federation
Russian Federation
1, Repin Str., Yekaterinburg, 620028.
M. V. Pavlichenko
Ural Research Institute of Maternal and Infant Care
Russian Federation
Russian Federation
1, Repin Str., Yekaterinburg, 620028.
Ya. Yu. Pospelova
Ural Research Institute of Maternal and Infant Care
Russian Federation
Russian Federation
1, Repin Str., Yekaterinburg, 620028.
N. A. Fedorova
Ural Research Institute of Maternal and Infant Care
Russian Federation
Russian Federation
1, Repin Str., Yekaterinburg, 620028.
References
1. Bunduki V., Ruano R., da Silva M.M. et al. Prognostic factors associated with congenital cystic adenomatoid malformation of the lung. Prenat. Diagn. 2000;20(6):459–464. DOI: 10.1002/1097-0223(200006)20:6<459::aid-pd851>3.0.co;2-f
2. Wilson R.D., Hedrick H.L., Liechty K.W. et al. Cystic adenomatoid malformation of the lung: review of genetics, prenatal diagnosis, and in utero treatment. Am. J. Med. Genet. A. 2006;140(2): 151–155. DOI: 10.1002/ajmg.a.31031
3. Mahle W.T., Rychik J., Tian Z.Y. et al. Echocardiographic evaluation of the fetus with congenital cystic adenomatoid malformation. Ultrasound Obstet. Gynecol. 2000;16(7):620–662. DOI: 10.1046/j.1469-0705.2000.00254.x
4. Davenport M., Warne S.A., Cacciaguerra S. et al. Current outcome of antenally diagnosed cystic lung disease. J. Pediatr. Surg. 2004;39(4):549–556. DOI: 10.1016/j.jpedsurg.2003.12.021
5. Nugent C.E., Hayashi R.H., Rubin J. Prenatal treatment of type I congenital cystic adenomatoid malformation by intrauterine fetal thoracentesis. J. Clin. Ultrasound. 1989;17(9):675–677. DOI: 10.1002/jcu.1870170912
6. Adzick N.S., Harrison M.R., Crombleholme T.M. et al. Fetal lung lesions: management and outcome. Am. J. Med. Genet. 1998;179(4):884–889. DOI: 10.1016/s0002-9378(98)70183-8
7. Adzick N.S., Harrison M.R., Flake A.W. et al. Fetal surgery for cystic adenomatoid malformation of the lung. J. Pediatr. Surg. 1993;28(6):806–812. DOI: 10.1016/0022-3468(93)90332-f
8. Crombleholme T.M., Coleman B., Hedrick H. et al. Cystic adenomatoid malformation volume ratio predicts outcome in prenatally diagnosed cystic adenomatoid malformation of the lung. J. Pediatr. Surg. 2002;37(3):331–338. DOI: 10.1053/jpsu.2002.30832
9. Clark S.L., Vitale D.J., Minton S.D. et al. Successful fetal therapy for cystic adenomatoid malformation associated with second-trimester hydrops. Am. J. Obstet. Gynecol. 1987;157(2):294–295. DOI: 10.1016/s0002-9378(87)80154-0
10. Dommergues M., Louis-Sylvestre C., Mandelbrot L. et al. Congenital adenomatoid malformation of the lung: when is active fetal therapy indicated? Am. J. Obstet. Gynecol. 1997;177(4):953–958. DOI: 10.1016/s0002-9378(97)70300-4
11. Schrey S., Kelly E.N., Langer J.C. et al Fetal thoracoamniotic shunting for large macrocystic congenital cystic adenomatoid malformations of the lung. Ultrasound Obstet. Gynecol. 2012;39(5):515–520. DOI: 10.1002/uog.11084
12. Ierullo A.M., Ganapathy R., Crowley S. et al. Neonatal outcome of antena tally diagnosed congenital cystic adenomatoid malformations. Ultrasound Obstet. Gynecol. 2005;26(2):150–153. DOI: 10.1002/uog.1920
13. Bermudez C., Perez-Wulff J., Bufalino G. et al. Percutaneous ultrasoundguided sclerotherapy for complicated fetal intralobar bronchopulmonary sequestration. Ultrasound Obstet. Gynecol. 2007;29(5):586–589. DOI: 10.1002/uog.3944
14. Bermudez C., Perez-Wulff J., Arcadipane M. et al. Percutaneous fetal sclerotherapy for congenital cystic adenomatoid malformation of the lung. Fetal Diagn. Ther. 2008;24(3):237–240. DOI: 10.1159/000151345
15. Lee F.L., Said N., Grikscheit T.C. et al. Treatment of congenital pulmonary airway malformation induced hydrops fetalis via percutaneous sclerotherapy. Fetal Diagn. Ther. 2012;31(4):264–268. DOI: 10.1159/000336226
Review
For citations:
Kosovtsova N.V., Pavlichenko M.V., Pospelova Ya.Yu., Fedorova N.A. Intrauterine Treatment of Nonimmune Fetal Dropsy with Type I Cystic Adenomatous Lung Malformation. Title. 2024;23(2):60-64. (In Russ.) https://doi.org/10.31550/1727-2378-2024-23-2-60-64
Views:
11
Email this article 